fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Dimethicone.

All products: general benefit

NYDA · DIN 02373785 · 50% w/w · Top Sol-50mL Pk

General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
NYDA · DIN 02373785 Manufacturer: G Pohl Boskamp GMBH & Co KG, hohenlockstedt; listing date 2013-10-31 Health Canada: Marketed since 2012-01-06 · brand NYDA · ATC P03AX05 DIMETICONE · form Solution · route Topical · ingredients DIMETHICONE 50 % · company G pohl-boskamp gmbh & co kg · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

NYDA: Formulary list price $22.42 per unit (the source does not state the unit; exact figure $22.4200). What the ministry pays, not the patient.

Ministry pays: $22.4200 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02373785)

Source record
DIN 02373785: NYDA Raw flags: sec3=Y Item: 840412020; group id 826; item number 2011; lccId None; manufacturer id GPB Source form: Top Sol-50mL Pk; strength: 50% w/w Recorded listing: General benefit Source prices (unrounded): $22.4200; ministry $22.4200 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02373785 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85900
Shortage status: not checked (no credentials)

Other products in the same Health Canada class (P03A, P03AX): coverage varies; not interchangeable

  • Isopropyl myristate (Resultz): general benefit
  • Permethrin (Nix Dermal Cream): general benefit
  • Piperonyl butoxide + pyrethrins (R & C Shampoo with Conditioner): general benefit
Other drugs in the same formulary class (84:04:12 Parasiticides) and how they are covered

Matched class: 84:04:12 Parasiticides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ISOPROPYL MYRISTATE, PERMETHRIN, PYRETHRINS & PIPERONYL BUTOXIDE 84:04:12 Parasiticides

ISOPROPYL MYRISTATE

· 2 products · General benefit · strengths: 50% · Top Sol-120mL Pk, Top Sol-240mL Pk

PERMETHRIN

· 4 products · General benefit · strengths: 5%, 1% · Cr, Cr Rinse, Lot

PYRETHRINS & PIPERONYL BUTOXIDE

· 1 products · General benefit · strengths: 0.33% & 3% · Topical Shampoo Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:12
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:08 Fungicides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Dimethicone 100 cSt (NYDA) is indicated for: Topical treatment of scalp hair in case of infestation with head lice (pediculosis capitis). If used as instructed, NYDA is also effective against nymphs and eggs (nits) 1.1 Pediatrics Clinical studies have been performed in children; therefore, NYDA can be used with children from ages 2 and up. 1.2 Geriatrics No clinical studies have been performed in elderly patients; however, the use of NYDA should not be of concern. https://pdf.hres.ca/dpd_pm/00066082.PDF PM date: Strasse 11, 2555 Source product: NYDA; DIN 02373785; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.